BioCardia, Inc.BCDANASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank53
3Y CAGR-16.0%
5Y CAGR-11.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-16.0%/yr
vs +1.1%/yr prior
5Y CAGR
-11.8%/yr
Recent deceleration
Acceleration
-17.1pp
Decelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$5.25M+19.6%
2024$4.39M-43.2%
2023$7.73M-12.5%
2022$8.83M+3.2%
2021$8.56M-12.8%
2020$9.81M+14.6%
2019$8.56M+1.3%
2018$8.45M+45.8%
2017$5.80M+74.1%
2016$3.33M-